Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

NCT01629849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Asthma

Interventions

DRUG: Placebo to BI 1021958 qd
DRUG: BI 1021958 bid
DRUG: Placebo to BI 1021958 bid
DRUG: BI 1021958 qd

Sponsor

Boehringer Ingelheim